What We're Reading: Page 213
Industry reads hand-picked by our editors
Jul 29, 2019
-
The Washington Post
Little-known makers of generic drugs played central role in opioid crisis, records show
-
The Wall Street Journal
For Many Diabetes Patients, Skin Patches and Phones Are Replacing Finger Pricks
-
Bloomberg
Swiss to Take On Big Pharma With Cheaper Cancer Treatment
Jul 26, 2019
-
The New York Times
McKinsey Advised Johnson & Johnson on Increasing Opioid Sales
-
Business Insider
Health insurance companies deny kids with SMA gene therapy Zolgensma
-
OneZero
CRISPR Could Be the Future of Disease Diagnosis
Jul 25, 2019
-
STAT
Senators float controversial changes to sweeping drug pricing bill
-
MedTech Dive
FDA directly links Allergan Biocell breast implants with cancer risk, prompting recall
-
Axios
How Express Scripts claws back money from pharmacists
-
Regulatory Focus
FDA's Woodcock Weighs in on Role of NIH in Drug Development
Jul 24, 2019
Jul 23, 2019
Jul 22, 2019
Jul 19, 2019
-
Bloomberg
How Do You Test a New Seasickness Drug? Take Pill, Set Sail
-
FiercePharma
Pharma's top jet-setting executives of 2018
-
Reuters
Canada warns U.S. against drug import plans, citing shortage concerns
-
Fortune
Protect at All Costs: How the Maker of the World’s Bestselling Drug Keeps Prices Sky-High
Previous
